Abstract
Novel alpha-glucosidase inhibitors with a tetrachlorophthalimide skeleton were prepared and their structure-activity relationships were analyzed. Among them, N-phenyl-4,5,6,7-tetrachlorophthalimide (CPOP: 2) and N-(4-phenylbutyl)-4,5,6,7-tetrachlorophthalimide (CP4P: 6) showed very potent inhibitory activity, being more potent than 1-deoxynojirimycin (dNM: 1). Mechanistic studies revealed that CPOP (2) and CP4P (6) inhibit alpha-glucosidase non-competitively and competitively, respectively.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
1-Deoxynojirimycin / chemistry
-
1-Deoxynojirimycin / pharmacology
-
Binding Sites
-
Catalytic Domain
-
Enzyme Inhibitors / chemistry*
-
Enzyme Inhibitors / metabolism
-
Enzyme Inhibitors / pharmacology*
-
Glycoside Hydrolase Inhibitors*
-
Inhibitory Concentration 50
-
Phthalimides / chemistry*
-
Phthalimides / metabolism
-
Phthalimides / pharmacology*
-
Structure-Activity Relationship
-
alpha-Glucosidases / metabolism
Substances
-
Enzyme Inhibitors
-
Glycoside Hydrolase Inhibitors
-
N-(4-phenylbutyl)-4,5,6,7-tetrachlorophthalimide
-
N-phenyl-4,5,6,7-tetrachlorophthalimide
-
Phthalimides
-
1-Deoxynojirimycin
-
alpha-Glucosidases